Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Tabless Tube Holder

By Drug Discovery Trends Editor | August 22, 2012

Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces two tabless tube holder accessories for its Strata and Strata-X lines of silica-based and polymeric solid phase extraction (SPE) sorbents. These accessories hold SPE tubes in 96-well spacing to integrate with automated systems. All Strata and Strata-X products are now available in the tabless 1 mL tube format, enabling the user to arrange multiple sorbents within the holders, adding flexibility for method development. Users can also remove and replace a single SPE tube should they make an error, which cannot be done with standard 96-well SPE plates. The Tabless Tube Holders are compatible with the Phenomenex vacuum manifold as well as positive pressure systems.

“Our new Tabless Tube Holders are easy to use and add flexibility to the workflow options using our Strata and Strata-X sorbents,” comments Erica Pike, brand manager for Phenomenex. “Our growing line of Strata and Strata-X products meets the sample preparation needs of a wide range of applications, including complex biological matrices.”

Strata and Strata-X SPE sorbents simplify the method development process for fast and efficient sample preparation prior to chromatography. They remove unwanted contaminants, including phospholipids, and are offered in a number of unique selectivities to cover a diverse range of analytes.

Phenomenex Inc.


Filed Under: Drug Discovery

 

Related Articles Read More >

EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE